骨成長刺激剤の世界市場：洞察、競合情勢、市場予測：2030年

世界の骨成長刺激剤の市場は、2023年に12億6,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に5.34％のCAGRで拡大し、2030年には17億3,000万米ドルに達すると予測されています。骨成長刺激剤市場は、変性骨関連疾患の蔓延、交通事故やスポーツ外傷などの事故や外傷事例の増加、様々な骨変性疾患を発症しやすい高齢者人口の負担増加、骨成長刺激剤に関する技術的に高度なデバイスの開発への注目の蓄積などの要因により、プラスの成長が促進されています。

骨成長刺激剤市場は、様々な理由により製品需要が伸びています。主要な要因の一つは、骨粗鬆症、変形性関節症などの様々な変性骨疾患の有病率の上昇です。国際骨粗鬆症財団（2023年）によると、骨粗鬆症に関連する骨折は世界で年間890万件以上発生しています。さらに、50歳以上の男性の約5人に1人、女性の3人に1人が骨が弱いために骨折しやすいと述べています。骨粗鬆症の骨は密度が低くなり、弱くなり、骨折しやすくなります。したがって、骨粗鬆症のような変性性骨疾患の世界の有病率の上昇は、筋骨格系の骨折の増加につながり、ひいては骨成長刺激剤の需要を増加させるとみられています。

骨成長刺激剤市場の成長をもたらすもう一つの主な要因は、変形性関節症、椎間板変性症などの骨変性疾患を発症しやすい高齢者人口の負担が増加していることです。国連のWorld Population Ageing 2019 highlightsによると、全世界で約7億300万人が65歳以上の高齢者でした。また、同報告書では、2050年までに老齢人口が15億人に増加すると推定しています。

当レポートでは、世界の骨成長刺激剤市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 骨成長刺激剤市場レポートのイントロダクション

第2章 骨成長刺激剤市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 骨成長刺激剤市場の主な要因分析

• 骨成長刺激剤市場の促進要因
• 骨成長刺激剤市場の抑制要因と課題
• 骨成長刺激剤市場の機会

第5章 骨成長刺激剤市場におけるポーターのファイブフォース分析

第6章 骨成長刺激剤市場に対するCOVID-19の影響分析

第7章 骨成長刺激剤の市場概要

• 製品別
• 用途別
• エンドユーザー別
• 地域別

第8章 骨成長刺激剤市場の世界の企業シェア分析-主要3～5社

第9章 骨成長刺激剤市場の企業と製品プロファイル

• Zimmer Biomet
• Orthofix Medical Inc.
• DJO, LLC
• Bioventus
• ITO Co., Ltd.
• BTT Health GmbH
• Stimulate Health
• Kinex Medical Company, LLC
• Fintek Bio-Electric Inc.
• Regen Lab SA
• Arthrex, Inc.
• Altis Biologics (Pty) Ltd
• TERUMO BCT, INC.
• Medtronic
• DePuy Synthes (Johnson & Johnson)
• T-Biotechnology
• Dr PRP USA LLC
• Ossatec Benelux BV

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Bone Growth Stimulators Market in Global (2021-2030)
• Table 4: Bone Growth Stimulators Market in Global by Product (2021-2030)
• Table 5: Bone Growth Stimulators Market in Global by Application (2021-2030)
• Table 6: Bone Growth Stimulators Market in Global by End User (2021-2030)
• Table 7: Bone Growth Stimulators Market in Global by Geography (2021-2030)
• Table 8: Bone Growth Stimulators Market in North America (2021-2030)
• Table 9: Bone Growth Stimulators Market in North America by Product (2021-2030)
• Table 10: Bone Growth Stimulators Market in North America by Application (2021-2030)
• Table 11: Bone Growth Stimulators Market in North America by End User (2021-2030)
• Table 12: Bone Growth Stimulators Market in North America by Country (2021-2030)
• Table 13: Bone Growth Stimulators Market in the US (2021-2030)
• Table 14: Bone Growth Stimulators Market in Canada (2021-2030)
• Table 15: Bone Growth Stimulators Market in Mexico (2021-2030)
• Table 16: Bone Growth Stimulators Market in Europe (2021-2030)
• Table 17: Bone Growth Stimulators Market in Europe by Product (2021-2030)
• Table 18: Bone Growth Stimulators Market in Europe by Application (2021-2030)
• Table 19: Bone Growth Stimulators Market in Europe by End User (2021-2030)
• Table 20: Bone Growth Stimulators Market in Europe by Country (2021-2030)
• Table 21: Bone Growth Stimulators Market in France (2021-2030)
• Table 22: Bone Growth Stimulators Market in Germany (2021-2030)
• Table 23: Bone Growth Stimulators Market in the United Kingdom (2021-2030)
• Table 24: Bone Growth Stimulators Market in Italy (2021-2030)
• Table 25: Bone Growth Stimulators Market in Spain (2021-2030)
• Table 26: Bone Growth Stimulators Market in Russia (2021-2030)
• Table 27: Bone Growth Stimulators Market in Rest of Europe (2021-2030)
• Table 28: Bone Growth Stimulators Market in APAC (2021-2030)
• Table 29: Bone Growth Stimulators Market in APAC by Product (2021-2030)
• Table 30: Bone Growth Stimulators Market in APAC by Application (2021-2030)
• Table 31: Bone Growth Stimulators Market in APAC by End User (2021-2030)
• Table 32: Bone Growth Stimulators Market in APAC by Country (2021-2030)
• Table 33: Bone Growth Stimulators Market in China (2021-2030)
• Table 34: Bone Growth Stimulators Market in Japan (2021-2030)
• Table 35: Bone Growth Stimulators Market in India (2021-2030)
• Table 36: Bone Growth Stimulators Market in Australia (2021-2030)
• Table 37: Bone Growth Stimulators Market in South Korea (2021-2030)
• Table 38: Bone Growth Stimulators Market in Rest of APAC (2021-2030)
• Table 39: Bone Growth Stimulators Market in Rest of World (2021-2030)
• Table 40: Bone Growth Stimulators Market in RoW by Product (2021-2030)
• Table 41: Bone Growth Stimulators Market in RoW by Application (2021-2030)
• Table 42: Bone Growth Stimulators Market in RoW by End User (2021-2030)
• Table 43: Bone Growth Stimulators Market in RoW by Region (2021-2030)
• Table 44: Bone Growth Stimulators Market in Middle East (2021-2030)
• Table 45: Bone Growth Stimulators Market in Africa (2021-2030)
• Table 46: Bone Growth Stimulators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Bone Growth Stimulators Market in Global (2021-2030)
• Figure 4: Bone Growth Stimulators Market in Global by Product (2021-2030)
• Figure 5: Bone Growth Stimulators Market in Global by Application (2021-2030)
• Figure 6: Bone Growth Stimulators Market in Global by End User (2021-2030)
• Figure 7: Bone Growth Stimulators Market in Global by Geography (2021-2030)
• Figure 8: Bone Growth Stimulators Market in North America (2021-2030)
• Figure 9: Bone Growth Stimulators Market in North America by Product (2021-2030)
• Figure 10: Bone Growth Stimulators Market in North America by Application (2021-2030)
• Figure 11: Bone Growth Stimulators Market in North America by End User (2021-2030)
• Figure 12: Bone Growth Stimulators Market in North America by Country (2021-2030)
• Figure 13: Bone Growth Stimulators Market in the US (2021-2030)
• Figure 14: Bone Growth Stimulators Market in Canada (2021-2030)
• Figure 15: Bone Growth Stimulators Market in Mexico (2021-2030)
• Figure 16: Bone Growth Stimulators Market in Europe (2021-2030)
• Figure 17: Bone Growth Stimulators Market in Europe by Product (2021-2030)
• Figure 18: Bone Growth Stimulators Market in Europe by Application (2021-2030)
• Figure 19: Bone Growth Stimulators Market in Europe by End User (2021-2030)
• Figure 20: Bone Growth Stimulators Market in Europe by Country (2021-2030)
• Figure 21: Bone Growth Stimulators Market in France (2021-2030)
• Figure 22: Bone Growth Stimulators Market in Germany (2021-2030)
• Figure 23: Bone Growth Stimulators Market in the United Kingdom (2021-2030)
• Figure 24: Bone Growth Stimulators Market in Italy (2021-2030)
• Figure 25: Bone Growth Stimulators Market in Spain (2021-2030)
• Figure 26: Bone Growth Stimulators Market in Russia (2021-2030)
• Figure 27: Bone Growth Stimulators Market in Rest of Europe (2021-2030)
• Figure 28: Bone Growth Stimulators Market in APAC (2021-2030)
• Figure 29: Bone Growth Stimulators Market in APAC by Product (2021-2030)
• Figure 30: Bone Growth Stimulators Market in APAC by Application (2021-2030)
• Figure 31: Bone Growth Stimulators Market in APAC by End User (2021-2030)
• Figure 32: Bone Growth Stimulators Market in APAC by Country (2021-2030)
• Figure 33: Bone Growth Stimulators Market in China (2021-2030)
• Figure 34: Bone Growth Stimulators Market in Japan (2021-2030)
• Figure 35: Bone Growth Stimulators Market in India (2021-2030)
• Figure 36: Bone Growth Stimulators Market in Australia (2021-2030)
• Figure 37: Bone Growth Stimulators Market in South Korea (2021-2030)
• Figure 38: Bone Growth Stimulators Market in Rest of APAC (2021-2030)
• Figure 39: Bone Growth Stimulators Market in Rest of World (2021-2030)
• Figure 40: Bone Growth Stimulators Market in RoW by Product (2021-2030)
• Figure 41: Bone Growth Stimulators Market in RoW by Application (2021-2030)
• Figure 42: Bone Growth Stimulators Market in RoW by End User (2021-2030)
• Figure 43: Bone Growth Stimulators Market in RoW by Region (2021-2030)
• Figure 44: Bone Growth Stimulators Market in Middle East (2021-2030)
• Figure 45: Bone Growth Stimulators Market in Africa (2021-2030)
• Figure 46: Bone Growth Stimulators Market in South America (2021-2030)
• Figure 47: Market Drivers
• Figure 48: Market Barriers
• Figure 49: Marker Opportunities
• Figure 50: PORTER'S Five Force Analysis

Bone Growth Stimulators Market By Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, Ultrasonic Bone Growth Stimulators}, Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP)), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, Others), By End-User (Hospitals, Home Care, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising demand for the prevalence of bone-related disorders and increasing cases of traumatic injuries

The Global Bone Growth Stimulators market was valued at USD 1.26 billion in 2023, growing at a CAGR of 5.34% during the forecast period from 2024 to 2030 to reach USD 1.73 billion by 2030. The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and others, the growing burden of the geriatric population who are susceptible to developing various bone degenerative disorders, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators among others.

Bone Growth Stimulators Market Dynamics:

The Bone Growth Stimulators market is witnessing a growth in product demand owing to various reasons, one of the key factors being the rising prevalence of various degenerative bone disorders such as Osteoporosis, Osteoarthritis. As per the International Osteoporosis Foundation (2023), over 8.9 million fractures related to osteoporosis occur annually worldwide. It further stated that about one in five men and one in three women over the age of 50 are susceptible to suffering from a fracture due to weak bones. The osteoporotic bones become less dense, become weak, and are more prone to fractures. Therefore, the rising global prevalence of degenerative bone diseases such as osteoporosis would lead to an increasing number of bone fractures of the musculoskeletal system, which in turn would increase the demand for Bone Growth Stimulators.

Another key factor responsible for the growth of the Bone Growth Stimulators market is the growing burden of the geriatric population who are more susceptible to developing bone degenerative disorders such as osteoarthritis, degenerative disc disorders, and others. According to the United Nations World Population Ageing 2019 highlights, approximately 703 million people were aged 65 years and above across the globe. Also, the report estimated the old age population to rise to 1.5 billion by the year 2050.

In addition, as per the World Health Organization 2022 statistics, globally, there were about 1 billion persons aged 60 years or over in the year 2020.

Furthermore, as per the data published by the Osteoarthritis Action Alliance (OAAA), 2020, in the year 2019, about 242 million people worldwide suffer from symptomatic and activity limiting osteoarthritis (OA) which is one of the common types of arthritis. The data also mentioned that about 43% of people with OA are 65 or older and 88% of people with OA are 45 or older in 2019.

Age is considered as one of the key risk factors associated with fractures and bone-related disorders, therefore, the rising elderly population is expected to lead to the rise in the patient population across the world, which in turn would lead to an increase in demand for Bone Growth Stimulators in the forecast period, which will drive the Bone Growth Stimulators market growth.

Along with the factors mentioned above, the growth of the Bone Growth Stimulators market is the surge in the cases of road traffic injuries. According to the World Health Organization factsheet (2023) on road traffic injuries, road traffic injuries are the leading cause of fatality in children and young adults in the age group 5-29 years globally. The same factsheet further stated that about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. Injuries of this nature may result in severe damage to the limbs depending on the location of trauma. Therefore, the increase in the cases of road traffic injuries and accidents is expected to contribute to the growing demand for Bone Growth Stimulators, thereby taking the Bone Growth Stimulators market growth forward during the forecast period.

However, limited medical reimbursements and the high cost of procedures may be certain limiting factors of the Bone Growth Stimulators market growth.

The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations and orthopedic procedures. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the Bone Growth Stimulators market.

Bone Growth Stimulators Market Segment Analysis:

Bone Growth Stimulators Market By Product (Bone Growth Stimulation Devices [Non-invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, Ultrasonic Bone Growth Stimulators}, Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP)), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, Others), By End-User (Hospitals, Home Care, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the Bone Growth Stimulators Market, the Capacitive Coupling (CC) Devices are estimated to hold the highest share in the Bone Growth Stimulators market during the forecast period.

Capacitive Coupling (CC) Devices offers several advantages as it does not require any surgery, causes less discomfort, and have fewer or no potential complications.

Because the system comes with a portable battery pack and no precise placement of the electrodes is necessary, the patient can remain relatively mobile as compared to the Pulsed Electromagnetic Field (PEMF) Devices, where precise placement of the coils is necessary and the patient must remain relatively immobile during treatment.

Therefore, considering the advantages associated with Non-invasive Bone Growth Stimulators, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Bone Growth Stimulators market in the forecast period.

North America is expected to dominate the overall Bone Growth Stimulators Market:

Among all the regions, North America is expected to account for the largest share in the Global Bone Growth Stimulators market. Factors such as the rising incidents of traumatic injuries due to falls, accidents, and others in the region. Moreover, increasing geriatric and obese people in the region, and rising physician and patient awareness about newly introduced treatment procedures and technologies, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bone Growth Stimulators Market.

For instance, in the US, an overall 48.3 million people suffered from traumatic injuries out of which motor-vehicle incidents totaled 4.5 million in the year 2019 as per the National Safety Council 2022 report.

As per the facts provided by the National Safety Council (NSC), a US-based non-profit organization, in 2019, irrespective of the use of exercise equipment, exercise-related injuries accounted for about 468,000 injuries, the most of any category of sports and recreation in the United States. It was followed by bicycling with about 417,000 injuries, while basketball with 404,000 injuries, and football, with 292,000 injuries, ranked third and fourth, respectively.

Moreover, the presence of key players such as Arthrex Inc., Stryker Corporation, Medtronic, and their strategic business activities for the development of new Bone Growth Stimulators for the treatment of various bone-associated disorders will propel the Bone Growth Stimulators market in the region. This in turn would provide a conducive growth environment for the North America region.

These kinds of products launch in the local markets, providing at-home care, thereby pushing the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population in the region is expected to boost the North America Bone Growth Stimulators market during the forecast period.

Bone Growth Stimulators Market Key Players:

Some of the key market players operating in the Bone Growth Stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, ITO Co., Ltd., BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC, Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd, TERUMO BCT, INC., Medtronic, DePuy Synthes (Johnson & Johnson), T-Biotechnology, Dr PRP USA LLC, Ossatec Benelux BV, and others.

Recent Developmental Activities in the Bone Growth Stimulators Market:

On February 23, 2020, Orthofix announced the approval by the FDA, of an updated version of its bone growth stimulator app, STIM onTrack.

On March 7, 2018, Orthofix won FDA approval in the US and CE Mark approval in the European Union for its next-gen PhysioStim bone growth stimulator devices.

Key Takeaways from the Bone Growth Stimulators Market Report Study

Market size analysis for current Bone Growth Stimulators market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Bone Growth Stimulators market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Bone Growth Stimulators market.

Various opportunities available for the other competitor in the Bone Growth Stimulators market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Bone Growth Stimulators market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Bone Growth Stimulators market growth in the coming future?

Target Audience who can be benefited from this Bone Growth Stimulators Market Report Study

Bone Growth Stimulators products providers

Research organizations and consulting companies

Bone Growth Stimulators-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Bone Growth Stimulators

Various End-users who want to know more about the Bone Growth Stimulators market and latest technological developments in the Bone Growth Stimulators market.

Frequently Asked Questions for Bone Growth Stimulators Market:

1. What are Bone Growth Stimulators?

A bone stimulator is a device that generates an electric current used to promote bone growth. It uses ultrasonic or pulsed electromagnetic waves. Bone stimulators are either external or surgically implanted into the area of the affected bone.

2. What is the market for Global Bone Growth Stimulators?

Global Bone Growth Stimulators market was valued at USD 1.26 billion in 2023, growing at a CAGR of 5.34% during the forecast period from 2024 to 2030 to reach USD 1.73 billion by 2030.

3. What are the drivers for Global Bone Growth Stimulators Market?

The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and others, the growing burden of the geriatric population who are susceptible to developing various bone degenerative disorders, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators.

4. Who are the key players operating in the Global Bone Growth Stimulators Market?

Some of the key market players operating in the Bone Growth Stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, ITO Co., Ltd., BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC, Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd, TERUMO BCT, INC., Medtronic, DePuy Synthes (Johnson & Johnson), T-Biotechnology, Dr PRP USA LLC, Ossatec Benelux BV, and others.

5. Which region has the highest share in Bone Growth Stimulators Market?

North America is expected to hold the highest share in the revenue in the Bone Growth Stimulators market during the forecast period. Factors such as the rising incidents of traumatic injuries due to falls, accidents, and others in the region. Moreover, increasing geriatric and obese people in the region, and rising physician and patient awareness about newly introduced treatment procedures and technologies, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bone Growth Stimulators Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Bone Growth Stimulators market growth in this region.

Table of Contents

1.Bone Growth Stimulators Market Report Introduction

2.Bone Growth Stimulators Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Bone Growth Stimulators Market Key Factors Analysis

• 4.1. Bone Growth Stimulators Market Drivers
  • 4.1.1. The Prevalence of Degenerative Bone-Related Disorders
  • 4.1.2. Increasing Cases of Accident and Traumatic Cases
  • 4.1.3. Technological Advancements in Product Development
• 4.2. Bone Growth Stimulators Market Restraints and Challenges
  • 4.2.1. Limited Medical Reimbursements
  • 4.2.2. The High Cost of Procedures
• 4.3. Bone Growth Stimulators Market Opportunities
  • 4.3.1. Improving the Product Design
  • 4.3.2. Targeting Emerging Markets for Product Launches

5. Bone Growth Stimulators Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Bone Growth Stimulators Market

7. Bone Growth Stimulators Market Layout

• 7.1. By Product
  • 7.1.1. Bone Growth Stimulation Devices
    • 7.1.1.1. Non-invasive Bone Growth Stimulators
    • 7.1.1.1.1. Combined Magnetic Field (CMF) Devices
    • 7.1.1.1.2. Capacitive Coupling (CC) Devices
    • 7.1.1.1.3. Pulsed Electromagnetic Field (PEMF) Devices
    • 7.1.1.1.4. Ultrasonic Bone Growth Stimulators
    • 7.1.1.2. Invasive Bone Growth Stimulators
  • 7.1.2. Bone Morphogenetic Proteins (BMP)
  • 7.1.3. Platelet-Rich Plasma (PRP)
• 7.2. By Application
  • 7.2.1. Spinal Fusion Surgeries
  • 7.2.2. Delayed Union & Nonunion Bone Fractures
  • 7.2.3. Oral & Maxillofacial Surgeries
  • 7.2.4. Others
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Home Care
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Bone Growth Stimulators Market, by Product
    • 7.4.1.2. North America Bone Growth Stimulators Market, by Application
    • 7.4.1.3. North America Bone Growth Stimulators Market, by End User
    • 7.4.1.4. North America Bone Growth Stimulators Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Bone Growth Stimulators Market, by Product
    • 7.4.2.2. Europe Bone Growth Stimulators Market, by Application
    • 7.4.2.3. Europe Bone Growth Stimulators Market, by End User
    • 7.4.2.4. Europe Bone Growth Stimulators Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.4.6. Russia
    • 7.4.2.4.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Bone Growth Stimulators Market, by Product
    • 7.4.3.2. Asia-Pacific Bone Growth Stimulators Market, by Application
    • 7.4.3.3. Asia-Pacific Bone Growth Stimulators Market, by End User
    • 7.4.3.4. Asia-Pacific Bone Growth Stimulators Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Bone Growth Stimulators Market, by Product
    • 7.4.4.2. RoW Bone Growth Stimulators Market, by Application
    • 7.4.4.3. RoW Bone Growth Stimulators Market, by End User
    • 7.4.4.4. RoW Bone Growth Stimulators Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Bone Growth Stimulators Market Global Company Share Analysis - Key 3-5 Companies

9. Bone Growth Stimulators Market Company and Product Profiles

• 9.1. Zimmer Biomet
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Orthofix Medical Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. DJO, LLC
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Bioventus
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. ITO Co., Ltd.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. BTT Health GmbH
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Stimulate Health
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Kinex Medical Company, LLC
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Fintek Bio-Electric Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Regen Lab SA
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Arthrex, Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Altis Biologics (Pty) Ltd
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. TERUMO BCT, INC.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Medtronic
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. DePuy Synthes (Johnson & Johnson)
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. T-Biotechnology
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Dr PRP USA LLC
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Ossatec Benelux BV
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us